Safety related to maximal cardiopulmonary exercise testing in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB) Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Prediction of complications after pneumonectomy in patients with pulmonary tuberculosis Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015
Effect of balance training within pulmonary rehabilitation Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2) Year: 2013
Evaluation of the impact of a pulmonary rehabilitation program on exercise capacity in LAM Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2015
Collapse therapy in cavitary pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014
Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with BA Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
Efficacy of moxifloxacin instead of ethambutol in the intensive phase of therapy in newly diagnosed pulmonary TB Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Effect of pulmonary rehabilitation on cardiac function during exercise in COPD Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1) Year: 2013
Cardiopulmonary exercise testing responses to initial treatment in Group 1 pulmonary hypertension Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020
Impact of pulmonary tuberculosis sequelae on functional status Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Management of pulmonary tuberculosis sequelae Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015
Exercise prescription and progression in Canadian pulmonary rehabilitation programs Source: International Congress 2016 – Latest insights into pulmonary rehabilitation Year: 2016
Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015
Effect of anti-tuberculosis treatment on body composition during the intensive phase Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Evolution of pulmonary TB in military recruits Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Surgical complications of destructive pulmonary tuberculosis and ways of their correction Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016
The effectiveness of pulmonary TB treatment in patients with organic liver diseases, depending on the way of administration of anti-TB drugs Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Exercise capacity after pulmonary endoarterectomy and its determinants Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights Year: 2015